Tuesday, September 20, 2016

UPDATE 1-Allergan to buy Tobira in push for NASH treatments

Sept 20 (Reuters) - Allergan Plc said it would buy

Tobira Therapeutics Inc in a deal worth up to $1.7

billion, about 19 times the company's current value, to get a

leg up in the race to develop...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)